Annexon, Inc. Profile Avatar - Palmy Investing

Annexon, Inc.

Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets disti…

Biotechnology
US, Brisbane [HQ]
Value per Employee (VpE) · Surveys · Talents

Employees Analysis

Employee Surveys

Employees Asked: -

No survey available at the moment.

End of ANNX's Analysis
CIK: 1528115 CUSIP: 03589W102 ISIN: US03589W1027 LEI: - UEI: -
Secondary Listings
ANNX has no secondary listings inside our databases.